Susan E. Jorge

De novo design of allosterically switchable protein assemblies

New promises and challenges in the treatment of advanced non-small-cell lung cancer

Understanding the molecular basis of the high oxygen affinity variant human hemoglobin Coimbra

Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation